Hexavalent, six-in-one vaccine can reduce spread of the disease and cut costs ANALYSIS | ESTHER NAKKAZI | Pertussis, or ...

University of Zagreb researcher Beata Halassy treated her breast cancer with an unproven virus-based therapy using viruses ...

The hope is that patients who are given the personalised vaccines have a better chance of long-term survival and cure' ...

Emergent BioSolutions (NYSE:EBS – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday. EBS has been the subject of several other ...

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

The phase 2 VacSYn clinical trial is testing a vaccine-like immunotherapy (ACI-7104.056 ... The most common adverse events in the trial are injection site reactions in 49% of participants and ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

“We have made significant pipeline progress advancing our novel cancer immunotherapies, and we remain highly encouraged by the potential for our platform to provide a meaningful, broadly applicable, ...

The Africa Centres for Disease Control and Prevention has approved the first locally-made diagnostic test for mpox, as the agency aims to stem outbreaks of the lethal disease on the continent.

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

Early diagnosis is crucial to prevent complications, and treatment options include medication, insulin injections, and ...